Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-10-01 to 2023-09-30
Current total value of award: $178850
Description: PROGENICS PHARMACEUTICALS INC:1106332 [23-000141] PYLARIFY FOR PROSTATE CANCER IMAGING